Full Text View
Tabular View
No Study Results Posted
Related Studies
AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
This study is currently recruiting participants.
Verified May 2013 by National Institutes of Health Clinical Center (CC)
Study NCT01445418   Information provided by National Institutes of Health Clinical Center (CC)

First Received on September 30, 2011.   Last Updated on May 14, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Ovarian Cancer
Additional conditions recognized in this trial
Breast Neoplasms
Ovarian Neoplasms
More general conditions related to this trial
Adnexal Diseases
Breast Diseases
Endocrine Gland Neoplasms
Endocrine System Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Gonadal Disorders
Neoplasms
Neoplasms by Site
Ovarian Diseases
Skin Diseases
Urogenital Neoplasms
Interventions listed in this trial
AZ2281
Carboplatin
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services